Skip to main content

Search

Study Title Study Sponsor Status Study Drug Trial Phase Study Protocol Number Site
Glargine Insulin versus Continuous Regular Insulin in Diabetic Surgical Patients Receiving Total Parenteral Nutrition King Faisal Specialist Hospital & Research Center Ongoing Lantus® 4 147 King Faisal Specialist Hospital and Research Center (Riyadh)
A randomised blinded placebo controlled trial of hydrocortisone in critically illpatients with septic shock University of Sydney Ongoing HYDROCORTISONE 4 GI-CCT3722 King Fahad Medical City (riyadh), King Khalid University Hospital (Riyadh)
Multi-Center Prospective Randomized Controlled Trial of Intracranial Pressure Monitoring in Patients with Severe Traumatic Brain Injury KAIMRC Ongoing N/A 4 RC11/056 King Abdulaziz Medical City NG (Riyadh)
LUMINOUS™: Study to observe the effectiveness and safety of ranibizumab through individualized patient treatment and associated outcomes Novartis Ongoing RANIBIZUMAB 4 RFB002A240 king khaled eye specialist hospital (riyadh)
Alx-Mcd-502 A Natural History Study Of Molybdenum Cofactor And Isolated Sulfite Oxidase Deficiencies Alexion Pharma International Sàrl. Completed N/A 4 ALX-MCD-502 King Fahad Medical City (Riyadh)
The Effect of Caffeine on the Narcoleptic Patients Randomized Controlled Clinical Trial King Saud University Ongoing Caffeine 4 E-15-1484 King Khalid University Hospital (Riyadh)
Effect of heparin 20 u /kg/hr. continuous infusion on central venous catheter related thrombosis in children. KAIMRC Ongoing HEPARIN 4 RC12/145 King Abdulaziz Medical City NG (Riyadh)
The Multi-National Gilenya Pregnancy Exposure Registry in Multiple Sclerosis Novartis Ongoing Fingolimod (Glienya) 4 FTY720D2404 King Faisal Specialist Hospital and Research Center (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh), King Fahad Medical City (Riyadh)
Randomised Controlled Trial of Meropenem versus Piperacillin-Tazobactam for Definitive Treatment of Bloodstream The University of Queensland, Australia Ongoing Meropenem / Piperacillin-Tazocin 4 MED0313 King Fahad Specialist Hospital (Dammam)
Evaluation of Changes in Quality of Life and Socio-Professional Status in Subjects with Moderate to Severe Plaque Psoriasis Treated with Adalimumab in Routine Medical Practice - EQUIPE AbbVie Completed Adalimumab 4 10241 King Faisal Specialist Hospital and Research Center (Riyadh)
View 671 - 680 From 774